CompletedNot Applicable

Antibiotic Prophylaxis in Lung-Transplant Recipients

Italy90 participantsStarted 2024-01-12

Plain-language summary

Retrospective, monocentric observational pharmacological cohort study including all adult patients who underwent lung transplantation at IRCCS Azienda Ospedaliero-Universitaria di Bologna from 1st January 2002 to 31st August 2023.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult (age ≥ 18 years) * Patients who underwent LT at IRCCS Azienda Ospedaliero-Universitaria di Bologna from 1st January 2002 to 31st August 2023 * Patients receiving peri-operative antibiotic prophylaxis according to internal guidelines at time of LT * Signed informed consent Exclusion Criteria: * Lack of clinical and/or laboratory data regarding type of early bacterial infection and/or antibiotic prophylaxis received after lung transplant

What they're measuring

Diagnosis of early postoperative infections and/or bacterial donor-derived infections

Timeframe: Retrospective recruitment period will span from January 2001 to August 2023, with a 60-day retrospective follow-up post-transplant

Trial details

NCT IDNCT06760143

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-31

View on ClinicalTrials.gov More Lung-transplant Recipients trials